Post-approval studies (Phase 4)Study completedNCT00107887
What this trial is testing
TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)
Who this might be right for
TuberculosisHIV Infections
Johns Hopkins University 17,415